Increasing Demand for Minimally Invasive Treatments is Projected to Fuel the Need for Medical Simulation Market

on
The global medical simulation market is valued at $863.5 million in 2014 and is expected to reach $2,069.2 million in 2019 at a CAGR of 19.1% during the forecast period of 2014 to 2019. The market growth can be attributed to a number of factors such as increasing healthcare costs, rising focus on patient safety, and technological advancements. Increasing demand for minimally invasive treatments and increasing consolidation of the market players are other major contributors to the growth of this market. However, a few pivotal factors hindering the growth of this market are high costs of simulators, limited availability of funds, and operational challenges faced by many players in this market.


In this report, the medical simulation market is broadly segmented into products and services, end users, and regions. Based on products the market is segmented as mannequin-based simulation, web-based simulation, and simulation software. Mannequin-based simulation is further classified into patient simulators, surgical simulators, endovascular simulators, ultrasound simulators, dental simulators, eye simulators, and task trainers. The surgical simulators market is further segmented as laparoscopic surgical simulators, arthroscopic surgical simulators, cardiovascular simulators, gynecology simulators, and others. Web-based simulation is further segmented into second life and serious games, whereas, the simulation software market is further classified into performance recording software and virtual tutors. On the other hand, the services market is segmented into vendor-based training services, custom consulting services, and educational societies’ services. The major end users of the healthcare simulation products and services are academic institutions, hospitals, and military organizations. The market is further divided into four major regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World (RoW). These regions are further analyzed at the country-level.
Patient simulators account for a major share of the medical simulation market. This segment is poised to grow at the highest CAGR during the forecast period. This is mainly attributed to the growing adoption of patient simulators by medical schools and hospitals across the globe to reduce the medical errors and thereby healthcare costs associated with it.

North America accounts for the largest share of the global healthcare simulation market, followed by Europe, Asia-Pacific, and RoW. Growth in the developed markets in North America and Europe is mainly driven by the development and adoption of innovative products and the presence of major companies in this region which improves the accessibility of medical simulation products and services. As opposed to the North American and European markets, the demand in the APAC and Latin American markets is primarily driven by the growth in the overall healthcare industry. With the rapid rise in the number of patients undergoing various complex surgeries as well as the increasing number of hospitals, there will be an upsurge in the demand for medical simulation products in these developing regions to train the medical practitioners.


The major players in the medical simulation market are CAE, Inc. (Canada), Laerdal Medical AS (Norway), 3D Systems, Inc. (U.S.), Simulab Corporation (U.S.), Simulaids, Inc. (U.S.), Limbs and Things, Ltd (U.K.), Kyoto Kagaku Co., Ltd (Japan), Mentice AB (Sweden), Surgical Science Sweden AB (Sweden), and Gaumard Scientific Company, Inc. (U.S.).

Comments

Post a Comment